PHASE II TRIAL OF ADJUVANT CHEMOTHERAPY WITH TRI-WEEKLY CARBOPLATIN PLUS DOCETAXEL IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER: INTERIM ANALYSIS

JOURNAL OF THORACIC ONCOLOGY(2012)

Cited 0|Views6
No score
Key words
NSCLC,adjuvant chemotherapy,carboplatin,docetaxel,treatment compliance,surgical resection
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined